Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions. Patients who participate in Excell’s clinical research trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions. We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating. Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.
Major Depressive Disorder Clinical Trials Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18-75
Generalized Anxiety Disorder (GAD) Trials Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively in adults with Generalized Anxiety Disorder. The investigational product is in the form of a tablet. Eligibility Criteria: Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18 and above
Schizophrenia Trial Summary: Study to evaluate the safety and efficacy of iloperidone in preventing relapse in participants with schizophrenia. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18-65
Social Anxiety Clinical Research Trials Summary Trial A: The study’s purpose is to evaluate the efficacy and safety of Fasedienol as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a nasal spray. Summary Trial B: The study’s purpose is to evaluate the efficacy and safety of BNC210 as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a tablet. Eligibility Criteria: Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18 to 65
Adolescent Migraine Trials Summary: Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraines are extremely common and disabling in children. The purpose of these studies are to evaluate the efficacy and safety of the investigational products Ubrogepant and Atogepant. Ubrogepant is a drug approved for the acute treatment of migraine in adults and Atogepant is a drug approved for the for the preventive treatment of episodic migraine in adults. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 12-17
For those interested in participating in clinical research trials, Excell has a variety of studies that are testing new or investigational medications at no cost to clinical research study participants! Learn more about how new treatments may help with your symptoms.
Clinical research trials offer patients new opportunities for diverse treatments and personalized care from healthcare professionals. These trials often provide financially feasible treatment options, contributing to medical progress and advancing patient care. The primary aim of clinical research trials is to establish the effectiveness and safety of new treatments, potentially offering cures or improved management for chronic conditions. Participating in these trials allows access to cutting-edge treatments while contributing to longer, higher-quality lives for others. To ensure the safety of patients during clinical research trials, Excell follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP). According to requirements of the Medical Board of California, medical providers at Excell Research are providing information about the Open Payments Database. The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov. This database was created so that patients can be informed of any possible influence pharmaceutical companies may have on their physician. As a dedicated research facility, the entirety of Excell Research’s income is from pharmaceutical companies; however, medical providers are paid for their work by Excell Research and not directly by any pharmaceutical company. Learn more about the company on the About Us page.
Active Clinical Trials and Studies
Clinical Research Trials
Excell Research Clinical Research StudiesQuick Sign Up Form
Excell Research Clinical Research StudiesWhy Participate?
Learn More About Clinical Research Trials
Participants
What are Clinical Research Trials?
New Treatments For Longer and Better-Quality Lives
Patient Safety
Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research
Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions. Patients who participate in Excell’s clinical research trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions. We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating. Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.
Major Depressive Disorder Clinical Trials Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18-75
Generalized Anxiety Disorder (GAD) Trials Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively in adults with Generalized Anxiety Disorder. The investigational product is in the form of a tablet. Eligibility Criteria: Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18 and above
Schizophrenia Trial Summary: Study to evaluate the safety and efficacy of iloperidone in preventing relapse in participants with schizophrenia. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18-65
Social Anxiety Clinical Research Trials Summary Trial A: The study’s purpose is to evaluate the efficacy and safety of Fasedienol as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a nasal spray. Summary Trial B: The study’s purpose is to evaluate the efficacy and safety of BNC210 as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a tablet. Eligibility Criteria: Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 18 to 65
Adolescent Migraine Trials Summary: Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraines are extremely common and disabling in children. The purpose of these studies are to evaluate the efficacy and safety of the investigational products Ubrogepant and Atogepant. Ubrogepant is a drug approved for the acute treatment of migraine in adults and Atogepant is a drug approved for the for the preventive treatment of episodic migraine in adults. Eligibility Criteria Key Inclusion Criteria: Key Exclusion Criteria: Patient Time Reimbursed? Yes Patient Travel Reimbursed? Yes Age: 12-17
For those interested in participating in clinical research trials, Excell has a variety of studies that are testing new or investigational medications at no cost to clinical research study participants! Learn more about how new treatments may help with your symptoms.
Clinical research trials offer patients new opportunities for diverse treatments and personalized care from healthcare professionals. These trials often provide financially feasible treatment options, contributing to medical progress and advancing patient care. The primary aim of clinical research trials is to establish the effectiveness and safety of new treatments, potentially offering cures or improved management for chronic conditions. Participating in these trials allows access to cutting-edge treatments while contributing to longer, higher-quality lives for others. To ensure the safety of patients during clinical research trials, Excell follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP). According to requirements of the Medical Board of California, medical providers at Excell Research are providing information about the Open Payments Database. The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov. This database was created so that patients can be informed of any possible influence pharmaceutical companies may have on their physician. As a dedicated research facility, the entirety of Excell Research’s income is from pharmaceutical companies; however, medical providers are paid for their work by Excell Research and not directly by any pharmaceutical company. Learn more about the company on the About Us page.
Active Clinical Trials and Studies
Clinical Research Trials
Excell Research Clinical Research StudiesQuick Sign Up Form
Excell Research Clinical Research StudiesWhy Participate?
Learn More About Clinical Research Trials
Participants
What are Clinical Research Trials?
New Treatments For Longer and Better-Quality Lives
Patient Safety
Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research